IHCAN Conference +
The same format as the
IHCAN Conferences but
in a bigger venue with
20 March 2021 18 September 2021, *NEW VENUE* 155 Bishopsgate, London
IHCAN Conference +
The same format as the IHCAN Conferences but in a bigger venue with more exhibitors
20 March 2021 18 September 2021, *NEW VENUE* 155 Bishopsgate, London
CPD HOURS EACH
“Low-carb GP” Dr David Unwin, FRCGP, the doctor who is revolutionising the NHS’s treatment of diabetes with nutrition – in many cases reversing the disease – is back by popular demand to share his inspirational experiences at the sharp end of an NHS practice.
Neuroscientist Dr Elisabeth Philipps, PhD, backs up evidence-based research information with experience as an IFM-recognised functional medicine practitioner. Her presentation last year on CBD and gut health provoked the most questions we’ve ever had from a conference audience: she is back with more answers!
In line with Dr Unwin’s discussion on the low carbohydrate diet for NIDDM and Dr Philipp’s discussion on the cannabinoid system/ gut brain link, Anne will be exploring what the evidence tells us about genetic single nucleotide polymorphisms associated with the low carbohydrate approach and diabetes. Do our genes tell us if we will be successful with a low carb approach? How do we know which clients will benefit more? Do our genes determine or predispose us to NIDDM and obesity?
For the full schedule, click here.
Lifestyle medicine rather than lifelong medication: My personal goal
“Low-carb GP” Dr David Unwin, FRCGP, the doctor who is revolutionising the NHS’s treatment of T2 diabetes with nutrition – in many cases reversing the disease – is back by popular demand to share his inspirational experiences at the sharp end of an NHS practice.
Last July Dr Unwin published a paper showing how diet may bring about significant improvements in blood pressure despite ‘deprescribing’ 20% of the antihypertensive drugs his patients were taking. So in his lecture this year he will be adding in details of how diet may help people with essential hypertension as well as non-alcoholic fatty liver disease, central obesity and type 2 diabetes using a better understanding of the physiology of insulin and an ability to explain this model to our patients. In this way rather than simply telling people what a good diet may be, they actually understand why it may be better for them and are in a better position to individualize their dietary choices.
Last year we investigated how to motivate people to improve their lifestyle. This year Dr Unwin plans to explore how to improve clinicians’ ability to maintain approaches that show initial promise including how to reframe failure.
About Dr David Unwin, MD
Dr. David Unwin, MD, is an award-winning general practitioner (or family doctor) known for pioneering the low-carb approach in his profession in the UK.
In 2016 he won the prestigious NHS Innovator of the Year award for his work with diabetes patients. On top of that, Dr. Unwin is the medical advisor at the popular Low Carb Program and is doing his best to spread knowledge about low carb among doctors, dietitians and nurses.
In 2017/18, his practice saved £57,000 on drugs for type 2 diabetes, hypertension and other conditions by offering patients a dietary alternative to medications.
Recently Dr. Unwin was named the ninth most influential general practitioner in the UK by GP magazine Pulse. Moreover, he is Clinical Expert in Diabetes at Fellowship of the UK Royal College of General Practitioners where he was elected as a Fellow in 2008.
Dr. Unwin has also written several peer-reviewed papers to strengthen the science behind low-carb diets.
The Endocannabinoid System & Gut-Brain Axis: CBD Support for a Healthy Gut & Mind
The Endocannabinoid System (ECS) is the missing link in Functional Medicine! As practitioners, we automatically connect and interpret the health and function of the gut-brain axis in conditions ranging from IBS to psychological disorders. But how often do you consider the ECS in cases of anxiety, depression or dysregulated gut microbiome?
The ECS is a complex cell-signalling system identified in the early 1990s and has widespread important modulatory roles throughout the brain, endocrine and immune tissues influencing neuronal networks, homeostasis, immune balance, inflammation and stress recovery.
Dr Elisabeth Philipps will draw on her scientific knowledge and clinical experience to provide information and case studies to enable you to understand and integrate the ECS into your practice; how to modulate this system through diet and food supplements and understanding the practical use of phytonutrients such as cannabidol (CBD) in maintaining balance within the ECS and gut-brain axis.
**In light of recent media attention regarding the use of CBD, Dr Elisabeth Philipps commented:**
The Foods Standards Agency (FSA) recently announced that it has set a deadline of 31st March 2021 for companies selling CBD products to submit a Novel Foods application or risk regulatory scrutiny. Reputable CBD groups have welcomed this statement, as it provides some clarity for regulation within the industry and offers a route towards continuing to provide consumers with safe and tested products, protecting reputable CBD companies and steering a direction for a compliant regulated CBD industry.
There are, however, still many technical questions to be answered, as part of the FSA announcement, and novel food status is not the only option to ensure safety and improve regulation within the industry. As such, a number of options are still being explored, none of which impact the consumer and the sale of reputable safe CBD products currently on the market.
There also continues to be (unwarranted) scaremongering from some parties but the status and availability of CBD products, right now, remains unchanged; as long as the CBD food supplement contains <0.2% THC and is correctly labelled then it can be legally sold, recommended and safely consumed.
If the FSA statement is taken at face value, and if the novel food status is upheld, then the technical aspects of the application will happen in the background and is unlikely to have any impact on reputable companies in the industry thus not impacting on quality products being available for consumers both now and in the future.
About Dr Elisabeth Philipps PhD
Dr Elisabeth Philipps is a clinical neuroscientist and functional medicine practitioner who runs a health consultancy specialising in nutritional neurology, the endocannabinoid system and phytocannabinoids including CBD and medical cannabis. She is founder of the Bliss Programme™, a personalised medicine approach to supporting the endocannabinoid system in chronic health conditions. Dr Elisabeth also provides education, food supplement development and cannabinoid medicine consultancy services to clinicians and businesses.
How much of a difference do genes make when determining the lifestyle approach for your client?
One big question is “How much of a difference do genes REALLY make when determining the lifestyle approach for your client?”
Answering that one will be our SNPs expert Anne Pemberton, MSc, PGCHE, PGCE (Autism), RGN, DipION, She’ll explore what the evidence tells us about genetic single nucleotide polymorphisms associated with the low-carbohydrate approach and diabetes. Do our genes tell us if we will be successful with a low-carb approach? How do we know which clients will benefit more? Do our genes determine or predispose us to NIDDM and obesity?
About Anne Pemberton MSc, PGCHE, PGCE(Autism), RGN, DipION, fHEA, mCNHC, fBANT, NMC
Anne’s career spans 30 years of cardiothoracic intensive care nursing, Her son’s diagnosis of ASD totally changed her career trajectory as she looked to natural therapies to support him. Anne retrained in psychology then later in Nutrition and higher education teaching. She practices functional medicine runs a busy international clinic specialising in Autism spectrum disorders and chronic fatigue syndrome. She is also a published co-author and established international speaker. Since 2008 Anne has been teaching academic and clinical modules on Nutritional therapy courses, She was course director for the MSC in Nutrition Science and Practice at the Northern College of Acupuncture in York, 2010-2017. Anne has a real passion for the study and practical application of Nutrigenomics. Her book Using nutrigenomics within personalised nutrition is due to be published this year. She has been regular contributor for IHCAN magazine.
9.30 – 10.00: Registration
10.00 – 11.30: Dr Elisabeth Philipps, PhD
11.30 – 12.00: Refreshments
12.00 – 13.00: Anne Pemberton MSc, PGCHE, PGCE(Autism), RGN, DipION, fHEA, mCNHC, fBANT, NMC
13.00 – 14.00: Lunch
14.00 – 15.00: Dr David Unwin
15.00 – 15.30: Refreshments
15.30 – 16.30: Dr David Unwin
- Abundance & Health
- Hifas Da Terra
- Invivo Clinical
- Kinetic Enterprises
- Lifecode GX
- Living Planet Distribution
- Natures Plus
- Nordic Laboratories
- Nouveau Health
- Pharma Nord
- Solgar UK
- Sun Chlorella
- The Good Guru
- Vitae Health Innovation
More to be confirmed in the coming weeks.
All food served is gluten and dairy-free.
The Energiser Breakfast
Assortment of gluten-free breads, pickles, sea salt butter
Wood platter of charcuterie and breakfast cheeses
Gluten-free, vegan muesli and granola
Fruit greek yogurts, toasted seeds and chia seeds
Sliced seasonal fruit
Selection of freshly blended juices
Lavazza coffee, Taylor’s English and herbal teas
The mid-morning break will have chef’s choice savoury snacks and smoothies.
Glazed orange and thyme chicken with roasted root vegetables
Roasted fillet of sea bass, niçoise salad, lemon oil
Vegan Thai red curry with cauliflower and potato served with sticky rice
Vegan caramelized apple and berry crumble with toasted seeds
The afternoon break will have the chefs choice of sweet bites and fruit smoothies.
Whilst we are all looking forward to returning to live events, we will still be taking precautions to ensure everyone at the event is safe. There will be extra cleaning in place, and hand sanitiser stations around the venue.
The venue will not have any restrictions in place; however, we will be keeping as much space between stands and seating areas as possible. Face masks are not a requirement put in place by the venue, but this is a personal choice for each individual.
Book your place
Proudly supported by